{
    "organizations": [],
    "uuid": "ed7ccfcdf8b2565da5bea1a052f1ee3b3aa66a7b",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-convert-pharmaceuticals-secures-eu/brief-convert-pharmaceuticals-secures-eur-13-6-million-to-develop-anti-cancer-drugs-idUSFWN1QI0X1",
    "ord_in_thread": 0,
    "title": "BRIEF-Convert Pharmaceuticals Secures EUR 13.6 Million To Develop Anti-cancer Drugs",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 28 (Reuters) - Convert Pharmaceuticals:\n* CONVERT PHARMACEUTICALS SAYS GRANTED EUR 13.6 MILLION IN EQUITY AND NON-DILUTIVE FUNDING BY INVESTORS DROIA ONCOLOGY VENTURES, MEUSINVEST AND SPINVENTURE Source text for Eikon: (Reuters.Briefs@thomsonreuters.com)\n ",
    "published": "2018-02-28T21:10:00.000+02:00",
    "crawled": "2018-02-28T15:37:33.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "convert",
        "pharmaceutical",
        "convert",
        "pharmaceutical",
        "say",
        "granted",
        "eur",
        "million",
        "equity",
        "funding",
        "investor",
        "droia",
        "oncology",
        "venture",
        "meusinvest",
        "spinventure",
        "source",
        "text",
        "eikon"
    ]
}